Nat Immun:发现iNKT免疫细胞发育所需的脂肪分子

2012-04-14 张笑 中国科学报

近日,国际著名杂志《自然—免疫学》Nature Immunology在线刊登了瑞士、中国等国科学家合作的研究成果“Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus,”,在文章中,研究者发现了一类脂肪分子,为一种独特早期应答免疫细胞的发育所

近日,国际著名杂志《自然—免疫学》Nature Immunology在线刊登了瑞士、中国等国科学家合作的研究成果“Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus,”,在文章中,研究者发现了一类脂肪分子,为一种独特早期应答免疫细胞的发育所必需。这种被称为“不变的自然杀手”(iNKT)的免疫细胞具有大量分泌细胞因子和影响其他免疫细胞应答的作用。

先前研究表明,iNKT细胞可以识别各种微生物脂肪分子;但是,发育中的胸腺iNKT细胞能识别的自生脂肪分子的种类却一直存在很多争议。

Gennaro De Libero和同事发现含醚类脂肪分子会选择胸腺iNKT细胞。也就是说,合成的含醚类脂肪分子会潜在地激活成熟的iNKT细胞并促进胸腺iNKT细胞的发育。

他们还注意到,如果缺少GNPAT这种能生产含醚类脂肪的酶,那么小鼠体内只会产生很少量的iNKT细胞并且该细胞无法在末梢组织中聚积。这项研究有助于进一步了解这种含醚类脂肪分子发育和存活的标准。(生物谷Bioon.com)

doi:10.1038/ni.2245
PMC:
PMID:

Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus

Federica Facciotti,1, 5 Gundimeda S Ramanjaneyulu,1 Marco Lepore,1 Sebastiano Sansano,1 Marco Cavallari,1 Magdalena Kistowska,1, 5 Sonja Forss-Petter,2 Guanghui Ni,3 Alessia Colone,4 Amit Singhal,4 Johannes Berger,2 Chengfeng Xia,3 Lucia Mori1, 4 & Gennaro De Libero1, 4

The development and maturation of semi-invariant natural killer T cells (iNKT cells) rely on the recognition of self antigens presented by CD1d restriction molecules in thymus. The nature of the stimulatory thymic self lipids remains elusive. We isolated lipids from thymocytes and found that ether-bonded mono-alkyl glycerophosphates and the precursors and degradation products of plasmalogens stimulated iNKT cells. Synthetic analogs showed high potency in activating thymic and peripheral iNKT cells. Mice deficient in the peroxisomal enzyme glyceronephosphate O-acyltransferase (GNPAT), essential for the synthesis of ether lipids, had significant alteration of the thymic maturation of iNKT cells and fewer iNKT cells in both thymus and peripheral organs, which confirmed the role of ether-bonded lipids as iNKT cell antigens. Thus, peroxisome-derived lipids are nonredundant self antigens required for the generation of a full iNKT cell repertoire.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=89742, encodeId=bd1289e429e, content=没人评论么, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocJY6moGTnYzC8V8lUl3k679Uxh0PVMjIamhoDYuSYr6D4KDKlbpuNuCKFlJaiaVrmFIrbseIWqUA/132, createdBy=ad571630249, createdName=马里奥8433, createdTime=Mon Jun 13 13:16:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879196, encodeId=3d1418e9196a6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 02 19:33:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751726, encodeId=95961e51726d2, content=<a href='/topic/show?id=ba8612842b3' target=_blank style='color:#2F92EE;'>#NKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12842, encryptionId=ba8612842b3, topicName=NKT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e936405699, createdName=xuruicheng, createdTime=Thu Jul 26 21:33:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989638, encodeId=ec221989638c1, content=<a href='/topic/show?id=13c698665d' target=_blank style='color:#2F92EE;'>#iNKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9866, encryptionId=13c698665d, topicName=iNKT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 25 01:33:00 CST 2012, time=2012-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346967, encodeId=fe29134696eaa, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2016-06-13 马里奥8433

    没人评论么

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=89742, encodeId=bd1289e429e, content=没人评论么, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocJY6moGTnYzC8V8lUl3k679Uxh0PVMjIamhoDYuSYr6D4KDKlbpuNuCKFlJaiaVrmFIrbseIWqUA/132, createdBy=ad571630249, createdName=马里奥8433, createdTime=Mon Jun 13 13:16:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879196, encodeId=3d1418e9196a6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 02 19:33:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751726, encodeId=95961e51726d2, content=<a href='/topic/show?id=ba8612842b3' target=_blank style='color:#2F92EE;'>#NKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12842, encryptionId=ba8612842b3, topicName=NKT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e936405699, createdName=xuruicheng, createdTime=Thu Jul 26 21:33:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989638, encodeId=ec221989638c1, content=<a href='/topic/show?id=13c698665d' target=_blank style='color:#2F92EE;'>#iNKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9866, encryptionId=13c698665d, topicName=iNKT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 25 01:33:00 CST 2012, time=2012-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346967, encodeId=fe29134696eaa, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-06-02 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=89742, encodeId=bd1289e429e, content=没人评论么, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocJY6moGTnYzC8V8lUl3k679Uxh0PVMjIamhoDYuSYr6D4KDKlbpuNuCKFlJaiaVrmFIrbseIWqUA/132, createdBy=ad571630249, createdName=马里奥8433, createdTime=Mon Jun 13 13:16:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879196, encodeId=3d1418e9196a6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 02 19:33:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751726, encodeId=95961e51726d2, content=<a href='/topic/show?id=ba8612842b3' target=_blank style='color:#2F92EE;'>#NKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12842, encryptionId=ba8612842b3, topicName=NKT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e936405699, createdName=xuruicheng, createdTime=Thu Jul 26 21:33:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989638, encodeId=ec221989638c1, content=<a href='/topic/show?id=13c698665d' target=_blank style='color:#2F92EE;'>#iNKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9866, encryptionId=13c698665d, topicName=iNKT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 25 01:33:00 CST 2012, time=2012-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346967, encodeId=fe29134696eaa, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-07-26 xuruicheng
  4. [GetPortalCommentsPageByObjectIdResponse(id=89742, encodeId=bd1289e429e, content=没人评论么, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocJY6moGTnYzC8V8lUl3k679Uxh0PVMjIamhoDYuSYr6D4KDKlbpuNuCKFlJaiaVrmFIrbseIWqUA/132, createdBy=ad571630249, createdName=马里奥8433, createdTime=Mon Jun 13 13:16:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879196, encodeId=3d1418e9196a6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 02 19:33:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751726, encodeId=95961e51726d2, content=<a href='/topic/show?id=ba8612842b3' target=_blank style='color:#2F92EE;'>#NKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12842, encryptionId=ba8612842b3, topicName=NKT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e936405699, createdName=xuruicheng, createdTime=Thu Jul 26 21:33:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989638, encodeId=ec221989638c1, content=<a href='/topic/show?id=13c698665d' target=_blank style='color:#2F92EE;'>#iNKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9866, encryptionId=13c698665d, topicName=iNKT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 25 01:33:00 CST 2012, time=2012-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346967, encodeId=fe29134696eaa, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-04-25 dingxiaobo
  5. [GetPortalCommentsPageByObjectIdResponse(id=89742, encodeId=bd1289e429e, content=没人评论么, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocJY6moGTnYzC8V8lUl3k679Uxh0PVMjIamhoDYuSYr6D4KDKlbpuNuCKFlJaiaVrmFIrbseIWqUA/132, createdBy=ad571630249, createdName=马里奥8433, createdTime=Mon Jun 13 13:16:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879196, encodeId=3d1418e9196a6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 02 19:33:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751726, encodeId=95961e51726d2, content=<a href='/topic/show?id=ba8612842b3' target=_blank style='color:#2F92EE;'>#NKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12842, encryptionId=ba8612842b3, topicName=NKT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e936405699, createdName=xuruicheng, createdTime=Thu Jul 26 21:33:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989638, encodeId=ec221989638c1, content=<a href='/topic/show?id=13c698665d' target=_blank style='color:#2F92EE;'>#iNKT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9866, encryptionId=13c698665d, topicName=iNKT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 25 01:33:00 CST 2012, time=2012-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346967, encodeId=fe29134696eaa, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-04-15 neurowu

相关资讯

Immunity:首次揭示树突细胞识别外源物机制有望开发下一代疫苗

预测性的人CLEC9A二维结构(S:半胱氨酸残基;Y:酪氨酸残基),图片来自Cristal Huysamen et al. CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes. June 13, 2008 The

J Alle Clin Immun:日科学家发现花粉症的主要“导火索”

近日,国际杂志Journal of Allergy and Clinical Immunology在线刊登了日本研究人员的最新研究成果“A critical role of IL-33 in experimental allergic rhinitis,”,文章中,研究者发现了花粉症的主要导火索。 每年春季日本大街上的“口罩族”蔚为壮观,花粉症成为很多人一年一季的“洗礼”。日本一个研究小组最新研

Science:揭示治疗传染病的新策略---抵抗感染

病原体能够直接对宿主组织造成伤害。宿主免疫系统通过耐受机制降低宿主中病原体数量。免疫反应也能够对宿主组织造成伤害。宿主能够通过降低病原体和免疫病理反应造成的直接伤害的耐受机制来降低成本。图片来自Science/AAAS。 免疫系统通过检测和消除入侵病原体而保护机体免受感染。这两种策略构成常规临床方法对抗传染性疾病的的基础。来自葡萄牙古尔班基安科学研究所(Instituto Gulbenkian

J. Immunol.:人自然杀伤细胞在异种移植排斥中起重要作用

细胞毒性T细胞和自然杀伤细胞互补性作用的示意图,图片来自维基共享资源。 来自西班牙Bellvitge生物医学研究所(Bellvitge Biomedical Research Institute)的研究人员首次研究人自然杀伤细胞(natural killer cell, NK)抗猪软骨细胞的反应。研究结果于2012年1月27日发表在Journal of Immunology期刊上,表明作为天然免

Nature:微生物群落的平衡性决定自身免疫疾病是否发生

银屑病,特定的真菌可以激活和一定免疫疾病有关系的免疫细胞的功能,而另外一些微生物,尤其是存在于人类皮肤上的细菌,可以起到抗炎症的作用。(Credit: © quayside / Fotolia) Copyright ©版权归生物谷所有,若未得到Bioon授权,请勿转载。 当对机体有益的微生物正常工作的时候,和自身免疫疾病如银屑病等相关免疫细胞便会主动起到抗炎症的功效,近日,

Cancer Res.:癌干细胞疫苗具有抗肿瘤疗效

癌干细胞(cancer stem cell)是一类能够抵抗化疗或者放疗的肿瘤细胞,能够让肿瘤再生从而导致肿瘤复发。尽管名字存在类似性,但是癌干细胞与胚胎干细胞存在很大的差别。 美国密歇根大学外科研究助理教授Qiao Li博士和同事们从两类具有免疫活性的小鼠模式动物中提取癌干细胞,然后利用它们制备疫苗。 “我们发现这些富集的癌干细胞具有免疫原性,相比于在以前的免疫治疗试验中通常使用不加选择的肿瘤